A clinical pharmacist survey of prophylactic strategies used to prevent adverse events of lipid-associated formulations of amphotericin B

Infect Dis (Lond). 2019 May;51(5):380-383. doi: 10.1080/23744235.2019.1568546. Epub 2019 Feb 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amphotericin B / adverse effects
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / adverse effects
  • Antifungal Agents / therapeutic use*
  • Cross-Sectional Studies
  • Drug Compounding
  • Drug-Related Side Effects and Adverse Reactions / prevention & control*
  • Humans
  • Invasive Fungal Infections / drug therapy*
  • Lipids / chemistry*
  • Pharmacists*
  • Surveys and Questionnaires

Substances

  • Antifungal Agents
  • Lipids
  • Amphotericin B